NetScientific's ProAxsis Inks Licensing Deal With University Of Geneva Mon, 22nd Feb 2021 09:30 (Alliance News) - NetScientific PLC on Monday said its portfolio company ProAxsis Ltd has entered a licensing agreement with the University of Geneva and University Hospital of Geneva, for the development of new assays against fractures and other metabolic bone diseases. ProAxsis is a Belfast-based diagnostics firm, in which life sciences-focused investor NetScientific holds a 95% interest in. Under the deal, ProAxsis will complete the technical validation of an assay developed by university resear...